Dr Walker has a broad base of translational renal research with interests in renal pharmacology, renal pathophysiology and drug nephrotoxicity, linked to the ongoing clinical research interests in the regulation of renal and cardiovascular hemodynamics and AKI. His clinical research program addresses a long- standing interest in renal hemodynamics, drug-induced alterations in renal function and nephrotoxicity, the role of renovascular hormones in the control of hypertension and renal disease, and cardiovascular risk factors in kidney disease. Dr Walker has also participated in a number of pivotal trials including IDEAL, SHARP, ASFAST, and PERFECT, and authored over 180 publications. Until 2011, he was actively involved in the Scientific Programme and Education Commit- tee for the ANZSN, responsible for the scientific program of its annual scientific meeting as well as overseeing the society s education program. Professor Walker is a member of the ISN Nexus and Forefronts Committees, as well as serving on the Caring for Australasians with Renal Impairment guideline committees for cardiovascular risk factors in renal disease and dialysis adequacy. He is also an Executive Council member of Asian Pacific Society of Nephrology and has a strong interest in developing links between Australia & New Zealand with South East Asia and the Pacific to further advance the scientific knowledge and research in all aspects of nephrology. Advisory Board: Fresenius SE Asia (no compensation) KDIGO CHAIRS Bertram L Kasiske, MD, is Professor of Medicine at the University of Minnesota, USA. He received his medical degree from the University of Iowa and completed his Internal Medicine residency and fellowship training in Nephrology at Hennepin County Medical Center where he is currently Director of Nephrology. Dr Kasiske is former Deputy Director of the United States Renal Data System and former Editor-in-Chief of American Journal of Kidney Diseases. 